REPEATED USE OF BRAF AND MEK INHIBITORS IN METASTATIC MELANOMA PATIENTS AFTER PROFRESSION ON BRAF AND МЕК INHIBITORS. LITERATURE REVIEW AND CLINICAL OBSERVATION
Development of new effective drugs for therapy of metastatic melanoma (BRAF/MEK inhibitors, PD1/CTLA4 blockers) requires additional studies of the optimal sequence of their use. But in many cases the duration of the effect of these medicinal products is limited by time even in their sequential use....
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
Remedium Group LLC
2017-11-01
|
| Serie: | Медицинский совет |
| Soggetti: | |
| Accesso online: | https://www.med-sovet.pro/jour/article/view/2162 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|